Clinical and Translational Medicine Impact Factor, Indexing, Ranking 2024

Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

《临床与转化医学》（Clinical and Translational Medicine）系一本国际性、同行评审且开放获取的期刊，旨在推动和加速将临床前研究转化为临床应用，并促进基础科学家与临床科学家之间的交流。该期刊强调新型生物技术、生物材料、生物工程、疾病特异性生物标志物、细胞与分子医学、组学科学、生物信息学、应用免疫学、分子成像、药物发现与开发，以及监管与健康政策在临床潜力与应用方面的研究。期刊聚焦于从实验室到病床边的转化医学方法，优先考虑那些能够产生与患者和疾病相关的假设与问题，并指导细胞与分子医学研究的临床研究和临床观察。《临床与转化医学》热忱欢迎临床医生、研究人员、政策制定者和产业界人士的投稿。